Xeris Biopharma Holdings XERS
NASDAQ XERS
$16.52 +0.69 (+4.36%)
At close: Nov 11, 2026 · 4:00 PM EST

Xeris Biopharma Holdings (XERS) Invested Capital (2020 - 2026)

Updated

Xeris Biopharma Holdings (XERS) reported Invested Capital of $242.86 million for Q2 2026, up 21.8% from $199.32 million a year earlier and up 3.7% from the prior quarter.

Analysis

Xeris Biopharma Holdings (XERS) Invested Capital (2020 - 2026) Analysis & Trends

For FY2025, Xeris Biopharma Holdings posted Invested Capital of $234.02 million, up 15.6% from FY2024.

  • Invested Capital has a five-year compound annual growth rate of 14.1% (FY2020 to FY2025).
  • By year, Invested Capital came in at $202.49 million in FY2024 (+10.0%), $184.15 million in FY2023 (-20.7%), $232.26 million in FY2022 (+26.7%) and $183.3 million in FY2021 (+51.8%).
  • The Q2 2026 figure ranks as the highest quarterly Invested Capital in data going back to Q4 2020.
  • Year over year, Invested Capital has now increased in each of the last four quarters, with growth averaging 7.9% over the last eight quarters.
  • The high point for year-over-year Invested Capital in five years was Q3 2022 (growth of 127.0%); the low point was Q4 2023 (a decline of 20.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $234.24 million (Q1 2026), $234.02 million (Q4 2025) and $218.61 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 89.77 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 126.18 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 76.32 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 98.72 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 45.14 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 68.36 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 39.27 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 151.97 Bn
10 Xeris Biopharma Holdings 2.89 Bn 2.41 Bn 94.80 Mn 238.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 238.50 Mn
Jun 30, 2026 242.86 Mn
Mar 31, 2026 234.24 Mn
Dec 31, 2025 234.02 Mn
Sep 30, 2025 218.61 Mn
Jun 30, 2025 199.32 Mn
Mar 31, 2025 194.64 Mn
Dec 31, 2024 202.49 Mn
Sep 30, 2024 187.90 Mn
Jun 30, 2024 211.20 Mn
Mar 31, 2024 220.50 Mn
Dec 31, 2023 184.15 Mn
Sep 30, 2023 194.29 Mn
Jun 30, 2023 201.82 Mn
Mar 31, 2023 217.67 Mn
Dec 31, 2022 232.26 Mn
Sep 30, 2022 193.55 Mn
Jun 30, 2022 212.01 Mn
Mar 31, 2022 234.09 Mn
Dec 31, 2021 183.30 Mn
API Access

Xeris Biopharma Holdings Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=XERS&period=max&api_key=YOUR_API_KEY